The efficacy and safety of sevelamer and lanthanum versus calcium-containing and iron-based binders in treating hyperphosphatemia in patients with chronic kidney disease: a systematic review and meta-analysis.

It remains unclear which phosphate binders should be preferred for hyperphosphatemia management in chronic kidney disease (CKD).